Seroprevalence of Toxoplasma gondii and Rubella virus IgG Antibodies among breast cancer women in Kirkuk City
DOI:
https://doi.org/10.32792/utq/utjsci/v13i1.1557Keywords:
IgG antibodies, Toxoplasma gondii, Rubella virus, seroprevalence, breast cancerAbstract
One of the most prevalent illnesses in the globe is toxoplasmosis. It affects a significant percentage of people worldwide. It affects all warm-blooded species, including humans, and is known to be asymptomatic. The 2nd most prevalent TORCH infections are rubella, which is brought on by the rubella virus (RV), and the parasite T. gondii. Infection risk is highest in patients with compromised immune systems, such as those with breast cancer.
This study aimed to evaluate seroprevalence of T. gondii and rubella infection among in breast cancer female.
This study included (160) female breast cancer patient and control groups, Data and sample collection started from 1 of September 2025 to Ended on January 2026, this study was conducted at Kirkuk specialized center for oncology and Hematology in Kirkuk city. The blood samples collected from female breast cancer patients at different ages. The blood drawing mechanism included obtaining the patient‘s consent initially, and drew 5 ml of venous blood after sterilizing the patient‘s arm. The blood was placed in a test tube with a yellow cap, and the gel tube was then separated from it by means of a centrifuge. After the serum was separated Regarding the blood, the serum was distributed into two Ependorf tubes for the purpose of storing and freezing it for using serological test by IgG antibodies to Toxoplasma gondii and Rubella virus in human serum can be quantitatively determined in vitro using immunoassay.
Received: 27-01-2026
Revised: 05-03-2026
Accepted: 16-03-2026
References
S. Abbasi, H. M. Khan, and M. Y. Khan, "Protective Effect of Pyridoxine on Lead Nitrate Induced Histomorphological Changes in Rat Liver," Life and Science, vol. 3, pp. 5-5, 2022.
E. S. Al-Malki, "Toxoplasmosis: stages of the protozoan life cycle and risk assessment in humans and animals for an enhanced awareness and an improved socio-economic status," Saudi Journal of Biological Sciences, vol. 28, pp. 962-969, 2021.
H. Akbar, M. Z. Shabbir, U. Ullah, and M. I. Rashid, "Development of human toxo igG ELISA kit, and false-positivity of latex agglutination test for the diagnosis of toxoplasmosis," Pathogens, vol. 10, p. 1111, 2021.
R. Alubaidi and A. Shareef, "Estimating the Level of Some Inflammatory Cytokines in the Serum of Women Exposed to Abortion and the Relationship with Toxoplasmosis," Journal of Education and Science, vol. 30, pp. 33-41, 2021.
Y. R. S. Al-Halbousi and H. S. Al-Warid, "Lipid profile parameters and adipokines among adolescents infected with toxoplasmosis," Iraqi Journal of Science, pp. 2410-2417, 2024.
M. Tork, S. Sarvi, H. Asgarian-Omran, M. Sadeghi, B. Basirpour, M. H. Nejad, et al., "Design and optimization of IgG avidity test for differentiating acute from chronic human toxoplasmosis: A systematic review and meta-analysis," Experimental Parasitology, vol. 268, p. 108883, 2025.
L.-Q. Xu, L.-J. Yao, D. Jiang, L.-J. Zhou, M. Chen, W.-Z. Liao, et al., "A uracil auxotroph Toxoplasma gondii exerting immunomodulation to inhibit breast cancer growth and metastasis," Parasites & vectors, vol. 14, p. 601, 2021.
H.-M. Ye, M.-J. Lu, Q. Liu, Y. Lin, L.-Y. Tang, and Z.-F. Ren, "Beneficial effect of Toxoplasma gondii infection on the prognosis of breast cancer was modified by cytokines," Clinical Epidemiology, pp. 469-481, 2023.
Y. Song, H. Yuan, X. Yang, Z. Yang, Z. Ren, S. Qi, et al., "The opposing effect of acute and chronic Toxoplasma gondii infection on tumor development," Parasites & vectors, vol. 17, p. 247, 2024.
H. Ye, X. Zhou, B. Zhu, T. Xiong, W. Huang, F. He, et al., "Toxoplasma gondii suppresses proliferation and migration of breast cancer cells by regulating their transcriptome," Cancer Cell International, vol. 24, p. 144, 2024.
S. Sakuragi, H. Liao, K. Yajima, S. Fujiwara, and H. Nakamura, "Rubella virus triggers type i interferon antiviral response in cultured human neural cells: involvement in the control of viral gene expression and infectious progeny production," International Journal of Molecular Sciences, vol. 23, p. 9799, 2022.
A. Cheng, K. Frey, G. N. Mwamba, K. A. McCarthy, N. A. Hoff, and A. W. Rimoin, "Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo," Vaccine: X, vol. 9, p. 100127, 2021.
A. J. Bennett, A. C. Paskey, A. Ebinger, F. Pfaff, G. Priemer, D. Höper, et al., "Relatives of rubella virus in diverse mammals," Nature, vol. 586, pp. 424-428, 2020.
T. Hakkarainen, Y. Hynninen, I. Haavisto, M. Nuutinen, P. Poikonen-Saksela, J. Mattson, et al., "EE435 cost-analysis of a machine learning-based clinical decision support system to guide resilience-strengthening intervention decisions in breast cancer treatment: The bounce study," Value in Health, vol. 26, pp. S134-S135, 2023.
D. D. Salmarini, P. V. Darsono, and H. Kusvitasari, "Relationship between maternal knowledge and compliance with measles-rubella immunization," Health Sciences International Journal, vol. 3, pp. 15-25, 2025.
D. Simões, S. Ehsani, M. Stanojevic, N. Shubladze, G. Kalmambetova, R. Paredes, et al., "Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond," Eurosurveillance, vol. 27, p. 2100930, 2022.
A. Abdoli, M. Barati, M. Pirestani, and A. Dalimi, "Screening of toxoplasmosis in cancer patients: a concern," Tropical doctor, vol. 49, pp. 31-34, 2019.
N. S. Hijjawi, M. J. Al-Khreisat, O. M. Abuyaman, A. M. Abdelfattah, E. M. Rababah, M. A. Al-Tamimi, et al., "Seroprevalence of Toxoplasma gondii in Cancer Patients Admitted to Hospitals of the Royal Medical Services in Jordan," Jordan Journal of Biological Sciences, vol. 11, 2018.
M. A. Merdaw, Z. A. Jaffar, Z. M. Ali, and H. H. Khalil, “Correlation of toxoplasmosis seroprevalence and serum level of interleukin-10 in Iraqi breast cancer women” Indian Journal of Forensic Medicine & Toxicology, vol. 14, no. 4, pp. 1973-1978, 2020.
H. Ye, M. Lu, Q. Liu, Y. Lin, L. Tang, and Z. Ren, “Beneficial effect of Toxoplasma gondii infection on the prognosis of breast cancer was modified by Cytokines” Clinical Epidemiology, vol. 15, pp. 469–481, 2023.
B. A. Al-Aboody, and N. K. Al-Rekaby, “Prevalence of toxoplasmosis among cancer patients in Thi-Qar province, Iraq” Journal of Biotechonology, vol. 16, no. 3, pp. 24–30, 2017.
I. A. Al-Tameemi, B. H. Abdullah, and S. J. Raisan, "Seroprevalence of Toxoplasma gondii among cancer patients in Basrah province/Iraq," World Journal of Pharmaceutical Research, vol. 8, pp. 193-199, 2018.
M. M. Assim and E. J. Saheb, "The association of severe toxoplasmosis and some cytokine levels in breast cancer patients," Iraqi Journal of Science, pp. 1189-1194, 2018.
O. A. Ali and A. K. Khalaf, "Seroprevalence, Histologic Grades and Stages in Breast Cancer Patients with Toxoplasmosis in Thi Qar Province/Southern Iraq," Thi-qar Medical journal, vol. 28, pp. 126-133, 2024.
S. Jhandi, B. A. Vera, J. Galindo, J. G. Montoya, and D. G. Contopoulos-Ioannidis, "Toxoplasma gondii and a Cancer Biology Dichotomy: A Systematic Review of Experimental Studies of Its Antitumor and Pro-Tumor Effects," Pathogens, vol. 15, p. 351, 2026.
Downloads
Published
License
Copyright (c) 2026 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
